GALNS regulatory update

EMEA's Committee for Orphan Medicinal Products (COMP) issued a positive opinion to grant Orphan Drug designation for BioMarin's GALNS to treat mucopolysaccharidosis IVA (MPS-IVA, Morquio's syndrome). ...